Geron | GERN - Aset Lancar





Aset Lancar Perubahan Tanggal
Amgen USD 31.48B 2.42B 2026-03
Bio Techne USD 637.43M 27.92M 2025-12
Cassava Sciences USD 97.71M 11.2M 2025-12
Cytokinetics USD 839.46M 77.51M 2026-03
Esperion Therapeutics USD 462.57M 102.11M 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Genmab DKK 2.88B 1.59B 2025-12
Geron USD 520.27M 2.07M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Incyte USD 5.48B 460.36M 2026-03
MacroGenics USD 219.94M 12.15M 2025-12
Novartis USD 26.61B 3.85B 2026-03
Novavax USD 850.82M 127.46M 2026-03